Admission Date:  [**2174-7-22**]       Discharge Date:  [**2174-10-15**]  Date of Birth:   [**2174-7-22**]       Sex:  M  Service: Neonatology  HISTORY OF PRESENT ILLNESS:  Baby [**Name (NI) **] [**Known lastname **] [**Known lastname 51236**] is an 811 gm, 26 [**1-18**] week gestation infant male born to a 33 year old gravida 1, para 0 to 1 mother with prenatal screens as follows:  0 negative, antibody negative, hepatitis B surface antigen negative, RPR nonreactive, Rubella immune Group B Streptococcus unknown.
She was treated with Magnesium Sulfate, Labetalol, Hydralazine and bedrest as well as betamethasone.
On the morning of delivery fetal heartrate decelerations were noted and the decision was made to deliver by emergent cesarean section.
He was treated with bulb suction and bag mask ventilation with good response of crying and spontaneous respirations.
The patient was intubated at four to five minutes of life and was treated with Surfactant.
Respiratory - [**Known lastname **] received a total of two doses of Surfactant with initial improvement of respiratory distress and weaning of ventilator settings.
This required increase in his ventilator settings.
He came off of CPAP on [**2174-9-10**], on to nasal cannula oxygen.
He weaned down on his nasal cannula oxygen and went into room air on [**2174-10-9**].
The patient was started on Aldactone and Diuril for chronic lung disease during his hospitalization.
He also apnea of prematurity and was started on caffeine.
Caffeine was discontinued on [**2174-9-28**], last episode of apnea of prematurity was [**2174-9-22**].
He received one course of Indomethacin with no residual patent ductus arteriosus on follow up echocardiograms.
Fluids - [**Known lastname **] was started on parenteral nutrition on day of life #0, enteral feeds were started on day of life #9.
He was also started on sodium chloride and [**Doctor First Name 233**]-Ciel supplements.
He continued to gain well on this regimen.
Bilirubin peaked oat 5.3 on day of life #1 and phototherapy was initiated.
Phototherapy was continued until day of life #7 and rebound bilirubin following discontinuation of phototherapy was 2.8.
The patient had bilateral inguinal hernias and then underwent bilateral inguinal hernia repair on [**2174-10-8**] along with a circumcision.
Infectious disease - [**Known lastname **] completed 48 hours of Ampicillin and Gentamicin for initial rule-out sepsis.
There was also the concern for the possibility of line sepsis with Staphylococcus epidermidis around day of life #13 which was treated with a ten day course of Vancomycin and Gentamicin.
Hematology - [**Known lastname **] received multiple transfusions.
He was treated during his hospitalization with iron and Vitamin D.  He continues on iron supplementation at the time of discharge.
Immunizations - [**Known lastname **] received his two month old immunizations including hepatitis B, DTAP, HIB, ITV and Prevnar.
Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1.
[**Known lastname **] meets the criteria for Synagis and received his first dosage of Synagis prior to discharge.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other caregivers should be considered for immunization against influenza to protect the infant.
Medications on discharge - Iron supplements and Poly-Vi-[**Male First Name (un) **].
Immunizations - Two month old immunizations have been given as well as first dose of Synagis for this season.
Status post apnea of prematurity 4.
Status post patent ductus arteriosus 6.
Bilateral inguinal hernias, status post repair 7.
